After dedicating the last 28 years to building one of the world’s leading cardiovascular centers, Dr. Fuster will continue to advance the clinical care, research, and innovative training at Mount Sinai Heart. Image courtesy of Mount Sinai Health System
October 19, 2022
Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart
October 19, 2022 — Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named…
Read More
Issuance of new reimbursement-related codes expected to accelerate the use and adoption of ECG-based cardiac dysfunction AI algorithms, including HeartSciences’ MyoVista
October 19, 2022
HeartSciences Announces Major Milestone with the Issuance of CPT Codes by the American Medical Association for ECG AI Analysis of Cardiac Dysfunction
October 19, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences, a medical technology company focused on saving…
Read More
For men and women, the risk factors for cardiovascular disease are largely the same, an extensive global study involving University of Gothenburg researchers shows.
October 19, 2022
Cardiovascular Disease Risks the Same in Both Sexes
October 19, 2022 — For men and women, the risk factors for cardiovascular disease are largely the same, an extensive…
Read More
HeartFlow is the first and only company to provide non-invasive anatomy, physiology, and plaque information based on coronary computed tomography angiography (CCTA)
October 18, 2022
HeartFlow Receives FDA 510(k) Clearance for its Plaque Analysis and RoadMap Analysis
October 18, 2022 —  HeartFlow, Inc., a leader in revolutionizing precision heart care, has received U.S. Food and Drug…
Read More
Gregory D. Casciaro
October 18, 2022
Foldax Appoints Gregory D. Casciaro as Chief Executive Officer
October 18, 2022 —  Foldax, Inc. announced that medtech veteran Gregory D. Casciaro has been named Chief Executive…
Read More
Abiomed’s 14 Fr Impella Low Profile Sheath and dilator set.
October 18, 2022
U.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheath
October 18, 2022 —  The United States Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed for…
Read More
Medtronic conducted a recall to inform health care providers and patients of battery performance issues.
October 18, 2022
FDA Provides Update on Medtronic's HeartWare Ventricular Assist Device (HVAD) System
October 18, 2022 — The U.S. Food and Drug Administration (FDA) is providing updates to the FDA website to include…
Read More
MedAlliance to be Acquired by Cordis
October 18, 2022
MedAlliance to be Acquired by Cordis
October 18, 2022 — Swiss-based medical technology company MedAlliance has announced it has entered into an agreement…
Read More
Significant findings from the highly-anticipated EPIC-STEMI study were presented during a late-breaking scientific session at the recent Transcatheter Cardiovascular Therapeutics (TCT) 2022 Annual Symposium in Boston, MA.
Christine Book
October 17, 2022
Dramatic Cholesterol Reduction from PCSK9 Inhibitor Achieved in EPIC-STEMI Trial
October 17, 2022 — Significant findings from the highly-anticipated EPIC-STEMI study were presented during a late-…
Read More
People with cardiovascular disease still have a high burden of risk factors for severe COVID
October 17, 2022
Smoking, Diabetes and Obesity - Not Preexisting Heart Disease - Bigger Risk of COVID-19 Death, Study Finds
October 17, 2022 —  A national study suggests that risk factors for cardiovascular disease, such as age, smoking and…
Read More
Low-cost blood pressure lowering drugs, statins and aspirin widely in the form of a single pill, also known as the polypill. McMaster University
October 17, 2022
The Polypill Could Avoid Millions of Premature Deaths, Heart Attacks and Strokes Every Year, Say Leading Cardiology Experts
October 17, 2022 —  Global Health has paid a deadly price for not using simple, low-cost blood pressure lowering drugs…
Read More
Allegheny Health Network’s Cardiovascular Institute announced today the expansion of its nationally recognized thoracic surgery program to AHN Wexford Hospital, marking the full-service hospital’s most recent milestone in providing access to the highest level of care to patients living in communities north of Pittsburgh. The program launched under the clinical direction of AHN cardiothoracic surgeon, Hiran C. Fernando, MD.
October 17, 2022
AHN Cardiovascular Institute Expands Thoracic Surgery Program to AHN Wexford Hospital
October 17, 2022 —  Allegheny Health Network’s (AHN) Cardiovascular Institute announced the expansion of its nationally…
Read More
Study data show clinically meaningful impact on quality of life and disease severity, even in the most complex patients
October 14, 2022
ABRE Clinical Study 36-Month Data Shows Sustained Effectiveness of Abre Venous Self-Expanding Stent System
October 14, 2022 —  Medtronic, a global leader in medical technology, announced the 36-month final results from the …
Read More
The HELIOSTAR Balloon Ablation Catheter's unique one-shot balloon technology enables pulmonary vein isolation in 12 seconds, with customized energy delivery and one integrated 3D mapping solution
October 14, 2022
Biosense Webster Launches HELIOSTAR in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations
October 14, 2022 —  Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch…
Read More
Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP testinG, of Heart Failure therapies) study, announced the premature termination of the trial.
October 14, 2022
STRONG-HF Study in Patients Admitted for Acute Heart Failure (HF) Terminated Early for Superior Efficacy
October 14, 2022 —  Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid…
Read More
The data, collected during the transition from intravenous (IV) to oral levosimendan in the open-label extension (OLE) of the HELP (Hemodynamic Evaluation of Levosimendan in PH-HFpEF) trial, were presented at the Heart Failure Society of America (HFSA) Scientific Sessions 2022
October 13, 2022
Positive Data Presented at HFSA Annual Meeting Demonstrate Effects of Oral Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
October 13, 2022 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing, and…
Read More
the U.S. Patent and Trademark Office has issued to the University of Iowa Research Foundation ("UIRF") U.S. Patent No. 11,414,704 titled COMPOSITIONS AND METHODS FOR DETECTING PREDISPOSITION TO CARDIOVASCULAR DISEASE, which is exclusively licensed to the Company from UIRF
October 13, 2022
Cardio Diagnostics Announces Issuance of U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease
October 13, 2022 —  Cardio Diagnostics, Inc. , a pioneering precision cardiovascular testing company, announced that…
Read More
Zach Williams wanted to be a cancer researcher, but quick success in another area refocused his research on cardiovascular science. He was awarded a National Institutes of Health grant to fund his research for two years. Image courtesy of Clayton Metz/Virginia Tech.
October 13, 2022
Virginia Tech Graduate Student Earns NIH Support to Explore Promising Heart Finding
October 13, 2022 —  Zach Williams thought he’d become a cancer researcher when he joined Virginia Tech’s Translational…
Read More
The Delphi study results show Philips’ integrated echocardiography solution provides the tools required for baseline risk stratification and monitoring of cardio-oncology patients as recommended by the latest European Society of Cardiology (ESC) guidelines
October 12, 2022
Panel of Experts Highlights Clinical and Operational Benefits of Philips’ Integrated Echocardiography Solution
October 12, 2022 —   Following the recent European Society of Cardiology (ESC) Congress in Barcelona, Spain last month…
Read More
Study investigates metformin and other candidate drugs through a network medicine approach
October 12, 2022
Cleveland Clinic Researchers Identify Diabetes Drug Metformin as Potential Atrial Fibrillation Treatment in Collaborative Research
October 12, 2022 —  Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now